Herbal Oasis Announces Distribution Agreement to Launch Statewide in Alabama and Select Florida Panhandle Markets
Herbal Oasis, a hemp-derived THC-infused social seltzer brand, has announced its distribution expansion into Alabama and select Florida Panhandle markets starting late March 2025. The alcohol-free beverage, owned by cbdMD, combines hemp-derived THC, CBG, and functional mushrooms.
Each 12-ounce can features:
- Hemp-Derived Delta-9 THC + CBG
- 2,500mg of functional mushrooms (Lion's Mane, Reishi, Cordyceps)
- Nano-liposomal technology for 10-15 minute onset
The product will be available across major Alabama cities and Florida Panhandle locations through grocery chains, convenience stores, wellness shops, and hospitality venues. According to Euromonitor International, hemp-derived THC beverage sales doubled in 2024 and are projected to reach $4.1 billion by 2028, representing a 1,600% increase from $239 million in 2023.
Herbal Oasis, un marchio di seltzer sociale infuso con THC derivato dalla canapa, ha annunciato l'espansione della sua distribuzione in Alabama e in alcuni mercati della Florida Panhandle a partire dalla fine di marzo 2025. La bevanda analcolica, di proprietà di cbdMD, combina THC derivato dalla canapa, CBG e funghi funzionali.
Ogni lattina da 12 once presenta:
- THC Delta-9 derivato dalla canapa + CBG
- 2.500mg di funghi funzionali (Lion's Mane, Reishi, Cordyceps)
- Tecnologia nano-liposomiale per un effetto in 10-15 minuti
Il prodotto sarà disponibile nelle principali città dell'Alabama e in alcune località della Florida Panhandle attraverso catene di supermercati, negozi di alimentari, negozi di benessere e strutture di ospitalità. Secondo Euromonitor International, le vendite di bevande con THC derivato dalla canapa sono raddoppiate nel 2024 e si prevede che raggiungano 4,1 miliardi di dollari entro il 2028, rappresentando un aumento del 1.600% rispetto ai 239 milioni di dollari del 2023.
Herbal Oasis, una marca de seltzer social infundido con THC derivado del cáñamo, ha anunciado su expansión de distribución en Alabama y en ciertos mercados de la Florida Panhandle a partir de finales de marzo de 2025. La bebida sin alcohol, propiedad de cbdMD, combina THC derivado del cáñamo, CBG y hongos funcionales.
Cada lata de 12 onzas presenta:
- THC Delta-9 derivado del cáñamo + CBG
- 2,500mg de hongos funcionales (Lion's Mane, Reishi, Cordyceps)
- Tecnología nano-liposomal para un inicio de efecto en 10-15 minutos
El producto estará disponible en las principales ciudades de Alabama y en ubicaciones de la Florida Panhandle a través de cadenas de supermercados, tiendas de conveniencia, tiendas de bienestar y lugares de hospitalidad. Según Euromonitor International, las ventas de bebidas con THC derivado del cáñamo se duplicaron en 2024 y se proyecta que alcancen 4.1 mil millones de dólares para 2028, lo que representa un aumento del 1,600% desde los 239 millones de dólares en 2023.
Herbal Oasis는 대마에서 유래한 THC가 함유된 소셜 셀처 브랜드로, 2025년 3월 말부터 앨라배마와 플로리다 팬핸들 지역으로 유통을 확장한다고 발표했습니다. cbdMD 소속의 이 무알콜 음료는 대마에서 유래한 THC, CBG, 그리고 기능성 버섯을 혼합한 제품입니다.
각 12온스 캔에는:
- 대마에서 유래한 Delta-9 THC + CBG
- 2,500mg의 기능성 버섯 (Lion's Mane, Reishi, Cordyceps)
- 10-15분 내에 효과가 나타나는 나노-리포좀 기술
이 제품은 앨라배마의 주요 도시와 플로리다 팬핸들 지역의 슈퍼마켓, 편의점, 웰니스 상점 및 환대 장소를 통해 판매될 예정입니다. Euromonitor International에 따르면, 대마에서 유래한 THC 음료의 판매는 2024년에 두 배로 증가했으며, 2028년까지 41억 달러에 이를 것으로 예상되며, 이는 2023년의 2억 3천9백만 달러에서 1,600% 증가한 수치입니다.
Herbal Oasis, une marque de seltzer social infusé au THC dérivé du chanvre, a annoncé son expansion de distribution en Alabama et dans certains marchés de la Florida Panhandle à partir de fin mars 2025. La boisson sans alcool, propriété de cbdMD, combine du THC dérivé du chanvre, du CBG et des champignons fonctionnels.
Chaque canette de 12 onces contient:
- THC Delta-9 dérivé du chanvre + CBG
- 2 500 mg de champignons fonctionnels (Lion's Mane, Reishi, Cordyceps)
- Technologie nano-liposomale pour un effet en 10-15 minutes
Le produit sera disponible dans les grandes villes de l'Alabama et dans certaines localités de la Florida Panhandle via des chaînes de supermarchés, des magasins de proximité, des boutiques de bien-être et des établissements d'hospitalité. Selon Euromonitor International, les ventes de boissons au THC dérivé du chanvre ont doublé en 2024 et devraient atteindre 4,1 milliards de dollars d'ici 2028, représentant une augmentation de 1 600 % par rapport à 239 millions de dollars en 2023.
Herbal Oasis, eine Marke für THC-infusierte soziale Seltzer auf Hanfbasis, hat ihre Vertriebsexpansion nach Alabama und in ausgewählte Märkte an der Florida Panhandle ab Ende März 2025 angekündigt. Das alkoholfreie Getränk, das im Besitz von cbdMD ist, kombiniert THC aus Hanf, CBG und funktionale Pilze.
Jede 12-Unzen-Dose enthält:
- Hanf-abgeleitetes Delta-9 THC + CBG
- 2.500mg funktionale Pilze (Lion's Mane, Reishi, Cordyceps)
- Nano-liposomale Technologie für einen Wirkungseintritt in 10-15 Minuten
Das Produkt wird in großen Städten Alabamas und an Standorten in der Florida Panhandle über Supermarktketten, Convenience-Stores, Wellness-Shops und Gastronomiebetriebe erhältlich sein. Laut Euromonitor International haben sich die Verkäufe von Hanf-abgeleiteten THC-Getränken im Jahr 2024 verdoppelt und sollen bis 2028 4,1 Milliarden Dollar erreichen, was einem Anstieg von 1.600 % gegenüber 239 Millionen Dollar im Jahr 2023 entspricht.
- Significant market expansion into Alabama and Florida Panhandle
- Operating in rapidly growing market projected to reach $4.1B by 2028
- Wide distribution network including grocery chains, convenience stores, and hospitality venues
- None.
Insights
cbdMD's distribution agreement for Herbal Oasis represents a strategic market expansion that aligns with significant growth projections in the hemp-derived THC beverage sector. With Euromonitor International forecasting market growth from
The multi-channel distribution strategy across Alabama and Florida Panhandle targets diverse retail environments including grocery chains, convenience stores, wellness shops, and hospitality venues. This broad approach maximizes consumer touchpoints and could accelerate adoption if properly executed.
Particularly noteworthy is the product's positioning at the intersection of several consumer trends: sober-curious alternatives, functional ingredients (mushrooms and cannabinoids), and health-conscious formulations. This differentiation may help the brand establish a defensible niche in the increasingly competitive alternative beverage market.
For a micro-cap company (
Charlotte, North Carolina--(Newsfile Corp. - April 8, 2025) - Herbal Oasis ("Oasis"), the hemp derived THC-infused social seltzer brand redefining how people connect, unwind, and celebrate life, is proud to announce that starting in late March, Oasis began arriving on shelves across Alabama and select counties in the Florida Panhandle, making it easier for people to grab Oasis's premium, alcohol-free beverage made for presence, clarity, and connection.
A New Era of Social Beverages
Oasis, a hemp derived THC-infused social seltzer, is designed to redefine how people connect, unwind, and celebrate life. Crafted for the sober-curious, health-conscious, and socially active, Oasis combines hemp-derived THC, CBG, and functional mushrooms to create a vibrant, elevated experience-without the regret. As consumers move toward alternative choices to alcohol to relax, Oasis offers a refreshing path forward: one that feels good, tastes great, and brings people together.
"We're excited to expand distribution into Alabama and Florida-this is a major launchpad for our mission to make Oasis the go-to beverage for modern socializing," said Ronan Kennedy, CEO of cbdMD, the parent company of Oasis. "Consumers are energized by and embracing the shift in the beverage landscape, and Oasis is perfectly positioned to lead the way."
London-based data analytics and research firm Euromonitor International estimates sales of hemp-derived THC beverages more than doubled in 2024 and are projected to balloon to
Formulated for Feel-Good Connection
Each 12-ounce can of Oasis is infused with:
Hemp-Derived Delta-9 THC + CBG for a gentle, balanced full spectrum effect
2,500mg of functional mushrooms including Lion's Mane, Reishi, and Cordyceps to support mental clarity, calm, and vitality
Nano-liposomal technology for fast onset (10-15 minutes)
Naturally flavored, gluten-free, vegan, and free from artificial ingredients, making it a perfect choice for health-conscious consumers
Rolling Out in Key Locations Across Alabama and the Florida Panhandle
Oasis will be available in grocery chains, convenience stores, boutique wellness shops, and hospitality venues across major Alabama cities like Birmingham, Mobile, Huntsville, and college towns like Tuscaloosa and Auburn, as well as resort destinations and nightlife hubs in the Florida Panhandle. This includes support for on-premise accounts such as bars, restaurants, and lounges.
Availability
Oasis began hitting shelves in Alabama and Florida in late-March, with additional locations launching throughout spring and summer.
About Herbal Oasis
Herbal Oasis is a premium THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. More information can be found at www.herbaloasis.com. Oasis is a subsidiary of cbdMD, Inc.
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products, and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products, and our ATRx brand of natural functional mushroom support. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD oil and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, or ATRxlabs.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified using words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements, including but not limited to expectations on our ability to continue as a going concern, increasing our revenues, the development or future sales of Oasis products, regaining compliance with NYSE American continued listing requirements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2024 as filed with the Securities and Exchange Commission (the "SEC") on December 17, 2024, and our other filings with the SEC. All forward-looking statements, including Euromonitor international projections, involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
1 THC-free is defined as below the level of detection using validated scientific analytical methods.
Contact Information:
cbdMD, Inc.
Ronan Kennedy
Chief Executive Officer and Chief Financial Officer
IR@cbdmd.com
(704) 445-3064
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/247772